Zobrazeno 1 - 2
of 2
pro vyhledávání: '"Osman Yaşkiran"'
Publikováno v:
Hematology, Transfusion and Cell Therapy, Vol 44, Iss , Pp S35-S36 (2022)
Objective: Rituximab, which is widely used in the treatment of B-cell lymphoma, is a chimeric monoclonal antibody directed against the CD20 antigen. Rituximab has many side effects, mainly allergic and neurological. Rituximab may cause thrombocytopen
Externí odkaz:
https://doaj.org/article/c6d9171e5445489db3e858d3b480806a
Autor:
Seyma Celikbilek Celik, Osman Yaşkiran, Sevgi Keles, Gökhan Aytekin, Esra Yaşkiran, Eray Yıldız, Recep Tunc, Fatih Çölkesen
Publikováno v:
Annals of Medical Research. :1
Aim: Selective immunoglobulin A (sIgA) deficiency is the most common primary immunodeficiency. Individuals with selective IgA deficiency are generally considered to be asymptomatic. In some patients, autoimmune diseases have been reported. Regulatory
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::f8a32ecb3ab0c4497aa50260032935c6
https://doi.org/10.5455/annalsmedres.2019.10.676
https://doi.org/10.5455/annalsmedres.2019.10.676